Interestingly, MT1 is highly expressed in SN (Lacoste et al., 2015) but is significantly reduced in SN of PD patients (Adi et al., 2010), suggesting that MT1 dysfunction might be a potential risk for PD. This evidence concerns the gene MTNR1A and Parkinson disease.